InterOcean Capital Group LLC cut its position in CME Group Inc. (NASDAQ:CME – Free Report) by 7.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,009 shares of the financial services provider’s stock after selling 151 shares during the quarter. InterOcean Capital Group LLC’s holdings in CME Group were worth $433,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of CME Group during the 4th quarter valued at $959,260,000. Capital Wealth Planning LLC acquired a new position in shares of CME Group during the 4th quarter worth $253,563,000. Capital World Investors raised its holdings in shares of CME Group by 8.7% during the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after buying an additional 1,172,575 shares in the last quarter. M&G Plc acquired a new position in shares of CME Group during the 1st quarter worth $156,631,000. Finally, CIBC Private Wealth Group LLC raised its holdings in shares of CME Group by 24.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 1,872,774 shares of the financial services provider’s stock worth $394,406,000 after buying an additional 368,864 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the company. Rosenblatt Securities reissued a “sell” rating and set a $187.00 price target (up previously from $185.00) on shares of CME Group in a report on Thursday, April 25th. JPMorgan Chase & Co. upped their target price on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday. Barclays upped their target price on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday. Piper Sandler lowered their target price on CME Group from $235.00 to $225.00 and set an “overweight” rating for the company in a report on Thursday. Finally, Morgan Stanley upped their target price on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 9th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $212.64.
CME Group Trading Up 1.1 %
Shares of CME stock traded up $2.13 on Thursday, hitting $199.38. The company had a trading volume of 2,080,024 shares, compared to its average volume of 1,968,668. The firm has a market cap of $71.79 billion, a P/E ratio of 22.68, a P/E/G ratio of 6.56 and a beta of 0.52. The stock’s 50-day moving average is $200.38 and its two-hundred day moving average is $206.98. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.01. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $223.80.
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating the consensus estimate of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.30 earnings per share. On average, equities research analysts anticipate that CME Group Inc. will post 9.77 earnings per share for the current fiscal year.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.31%. CME Group’s payout ratio is 52.33%.
Insider Activity at CME Group
In related news, CEO Terrence A. Duffy sold 40,000 shares of the company’s stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the sale, the chief executive officer now owns 67,455 shares in the company, valued at approximately $14,226,934.05. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, insider Hilda Harris Piell sold 7,140 shares of the company’s stock in a transaction dated Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the sale, the insider now owns 29,256 shares in the company, valued at approximately $6,153,999.60. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 40,000 shares of the company’s stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $210.91, for a total value of $8,436,400.00. Following the sale, the chief executive officer now owns 67,455 shares in the company, valued at approximately $14,226,934.05. The disclosure for this sale can be found here. Insiders have sold a total of 54,290 shares of company stock worth $11,393,700 in the last 90 days. Corporate insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- The Most Important Warren Buffett Stock for Investors: His Own
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- What is the S&P/TSX Index?
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.